(Total Views: 277)
Posted On: 03/04/2020 2:28:38 PM
Post# of 36567
Re: skipper1072 #13835
So the part about peptide vaccines not being easily mass-produced does not apply to NGIO. We have a synthetic peptide vaccine which is easily produced.
Quote:
The disadvantage, De Groot says, is peptide vaccine cannot be easily mass-produced, and they don’t protect against infection.
Read More: https://investorshangout.com/post/view?id=569...z6FkZmjN4B
(0)
(0)
